Price
Target price
€0.76
€0.76
2.220%
0.016
2.220%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Tempramed Technologies Ltd. Stock
Tempramed Technologies Ltd. gained 2.220% today.
Pros and Cons of Tempramed Technologies Ltd. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
TempraMed Enters Strategic Media Partnership with Dr. Phil’s Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States
Access to an audience of over 19 million individuals monthly will expand national exposure, and supports scalable demand generation across B2C and B2B channels for TempraMed’s full product
TempraMed Launches New Product “VIVI Med™, Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional
TempraMed Receives Positive Response on Payor Reimbursement Model Driving Significant Return on Investment for Medical Payor Coverage
Validation is expected to accelerate TempraMed’s path to payor reimbursement for product portfolio
Highlights
- ROI model validated for savings and metrics by Validation